Washout of heme-containing proteins dramatically improves tetrazolium-based infarct staining

Journal of Pharmacological and Toxicological Methods

Volumn 55, Issue 2, 2007, Pages 201-208

  Pitts, Kelly R ^a   Stiko, Ann ^b   Buetow, Bernard ^a   Lott, Fred ^a   Guo, Ping ^a   Virca, Duke ^a   Toombs, Christopher F ^a  

^a AMGEN INC   (United States)

^b PFIZER INC   (United States)

Author keywords

Heme; Hemorrhage; Infarct; Methods; Rat; TTC

Indexed keywords

CYTOCHROME C; DYE; HEMOGLOBIN; HEMOPROTEIN; MYOGLOBIN; TETRAZOLIUM; TRIPHENYLTETRAZOLIUM;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PRESERVATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MOLECULAR WEIGHT; NONHUMAN; RAT; REPERFUSION INJURY; STAINING; TISSUE SECTION;

ANIMALS; ARTIFACTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORING AGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEMEPROTEINS; HEMORRHAGE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; SEQUENCE ANALYSIS, PROTEIN; STAINING AND LABELING; TETRAZOLIUM SALTS;

RATTUS;

EID: 33846871479     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2006.06.005     Document Type: Article

References (19)

1. Aartsen W.M., Pelsers M.M., Hermens W.T., Glatz J.F., Daemen M.J., and Smits J.F. Heart fatty acid binding protein and cardiac troponin T plasma concentrations as markers for myocardial infarction after coronary artery ligation in mice. Pflugers Archive - European Journal of Physiology 439 (2000) 416-422
2. Adachi Y., Saito Y., Kishimoto I., Harada M., Kuwahara K., Takahashi N., et al. Angiotensin II Type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice. Circulation 107 (2003) 2406-2408
3. Agata J., Chao L., and Chao J. Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction. Hypertension 40 (2002) 653-659
4. Alhadi H.A., and Fox K.A. Do we need additional markers of myocyte necrosis: The potential value of heart fatty-acid-binding protein. QJM 97 (2004) 187-198
5. Altman F.P. Tetrazolium salts and formazans. Progress in Histochemistry and Cytochemistry 9 (1976) 1-56
6. Cameron V.A., Rademaker M.T., Ellmers L.J., Espiner E.A., Nicholls M.G., and Richards A.M. Atrial (ANP) and brain natriuretic peptide (BNP) expression after myocardial infarction in sheep: ANP is synthesized by fibroblasts infiltrating the infarct. Endocrinology 141 (2000) 4690-4697
7. Hama N., Itoh H., Shirakami G., Nakagawa O., Suga S., Ogawa Y., et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (1995) 1558-1564
8. Jestaedt R., and Sandritter W. Experiences with the TTC-(triphenyltetrazolium chloride-) reaction for the pathological-anatomical diagnosis of fresh myocardial infarct. Zeitschrift für Kreislaufforschung 48 (1959) 802-809
9. Johns T.N., and Olsen B.J. Experimental myocardial infarction. I. A method of coronary occlusion in small animals. Annals of Surgery 140 (1954) 675-682
10. Lu L., Chen S.S., Zhang J.Q., Ramires F.J., and Sun Y. Activation of nuclear factor-kappaB and its proinflammatory mediator cascade in the infarcted rat heart. Biochemical and Biophysical Research Communications 321 (2004) 879-885
11. Manning A.S., Bruyninckx C., Ramboux J., and Chatelain P. SR 33589, a new amiodarone-like agent: Effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. Journal of Cardiovascular Pharmacology 26 (1995) 453-461
12. *1. Journal of the American College of Cardiology 27 (1996) 714-719
13. Seeland U., Kouchi I., Zolk O., Jockenhovel F., Itter G., Linz W., et al. Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats. European Journal of Heart Failure 5 (2003) 241-246
14. Stanton L.W., Garrard L.J., Damm D., Garrick B.L., Lam A., Kapoun A.M., et al. Altered patterns of gene expression in response to myocardial infarction. [see comment]. Circulation Research 86 (2000) 939-945
15. Tarnavski O., McMullen J.R., Schinke M., Nie Q., Kong S., and Izumo S. Mouse cardiac surgery: Comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiological Genomics 16 (2004) 349-360
16. Thorin E., Lucas M., Cernacek P., and Dupuis J. Role of ETA receptors in the regulation of vascular reactivity in rats with congestive heart failure. American Journal of Physiology. Heart and Circulatory Physiology 279 (2000) 844-851
17. Toombs C.F., Moore T.L., and Shebuski R.J. Cardioprotection with U-89232 is not reversible with glibenclamide: Evidence of a novel anti-ischemic agent derived from cromakalim. Pharmacology 49 (1994) 96-104
18. Weinberg E.O., Shimpo M., De Keulenaer G.W., MacGillivray C., Tominaga S., Solomon S.D., et al. Expression and regulation of ST2, an Interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106 (2002) 2961-2966
19. Yue P., Long C.S., Austin R., Chang K.C., Simpson P.C., and Massie B.M. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype. Journal of Molecular and Cellular Cardiology 30 (1998) 1615-1630